The incidence of dermatologic disease among people with HIV decreased from 2011 to 2023, but it remains prevalent.

The challenge with curing the Human Immunodeficiency Virus (HIV) is that it tends to hide dormant in cells, evading the ...

According to the new study, HIV achieves this with a tissue-specific approach, cloaking itself in a host cell's DNA by ...

Gilead Sciences, Inc. (Nasdaq: GILD) will present new findings from its antiviral research and development programs at IDWeek, taking place October 19-22 in Atlanta, GA. Data from 34 presentations ...

If someone becomes infected with HIV and does not seek timely treatment, the infection gradually progresses through three stages. Each stage has different symptoms and risks. HIV AIDS: If a person ...

For the 2.3 million residents of Lesotho, the announcement of massive cuts to the U.S. aid that sustained much of the small ...

The investigational once-daily regimen DOR/ISL was effective and well-tolerated among women and men with HIV-1 infection.

Omega House Hospice opened in 1986, primarily serving the LGBT population and those dying of HIV/AIDS. While it's population ...

With AIDS Walk L.A. days away, Phill Wilson reflects on decades of HIV/AIDS research and prevention and looks ahead as those ...

It’s a red-letter day for Scott Blades, who will receive the Center for Help and Hope 2025 Leadership Award at the Red Concert on Sunday, March 9 at Three Canyon, 4999 N. Sabino Canyon Road. The award ...

For over three decades, HIV has played an elaborate game of hide-and-seek with researchers, making treating—and possibly even curing—the disease a seemingly insurmountable obstacle to achieve. But ...

Just over 40 years have passed since the first HIV/AIDS case was diagnosed in Canada, and remarkable progress has been made in treating the disease. When it first emerged in the late 1970s, it was ...